AN2 Therapeutics Price Chart
AN2 Therapeutics Volume Chart
AN2 Therapeutics Market Segments
After Hours
-0.03(-0.63%)
| Open | $4.78 |
|---|---|
| Close | $4.75 |
| Low | $4.75 |
| Low Change | -0.03 (-0.63%) |
| High | $4.78 |
| High Change | +0.00 (+0.00%) |
| Range | $0.03 |
| Volume | 682 |
| Dollar Volume | $3.24K |
Regular Trading Hours
+0.06(+1.17%)
| Open | $4.70 |
|---|---|
| Close | $4.76 |
| Low | $4.50 |
| Low Change | -0.20 (-4.26%) |
| High | $4.95 |
| High Change | +0.25 (+5.32%) |
| Range | $0.45 |
| Volume | 388.591K |
| Dollar Volume | $1.85M |
Premarket
-0.01(-0.22%)
| Open | $4.65 |
|---|---|
| Close | $4.64 |
| Low | $4.64 |
| Low Change | -0.01 (-0.22%) |
| High | $4.65 |
| High Change | +0.00 (+0.00%) |
| Range | $0.01 |
| Volume | 1.5K |
| Dollar Volume | $6.96K |
After Hours Yesterday
*No Trades in Segment
Regular Trading Hours Yesterday
+0.01(+0.22%)
| Open | $4.64 |
|---|---|
| Close | $4.65 |
| Low | $4.58 |
| Low Change | -0.06 (-1.29%) |
| High | $5.00 |
| High Change | +0.36 (+7.76%) |
| Range | $0.42 |
| Volume | 278.92K |
| Dollar Volume | $1.30M |
Premarket Yesterday
+0.21(+4.77%)
| Open | $4.40 |
|---|---|
| Close | $4.61 |
| Low | $4.40 |
| Low Change | 0.00 (0.00%) |
| High | $4.61 |
| High Change | +0.21 (+4.77%) |
| Range | $0.21 |
| Volume | 3.692K |
| Dollar Volume | $17.02K |
AN2 Therapeutics Moving Averages
| 5 Day Moving Average (SMA5) | $4.49 |
|---|---|
| 10 Day Moving Average (SMA10) | $4.60 |
| 20 Day Moving Average (SMA20) | $4.42 |
| 50 Day Moving Average (SMA50) | $4.04 |
| 100 Day Moving Average (SMA100) | $2.59 |
| 200 Day Moving Average (SMA200) | $1.88 |
AN2 Therapeutics Statistics
| Average Volume (30 Days) | 305.46K |
|---|---|
| P/E Ratio (Current) | -4.40 |
| EPS (Current) | -$0.98 |
| Dividend Yield | 0.00% |
| Free Cash Flow | — |
| Cash Ratio | 2.29 |
| Current Ratio | 6.87 |
| Quick Ratio | 6.87 |
| Debt to Equity | 0.00 |
| Enterprise Value | $135.29M |
| EV to EBITDA | -3.55 |
| EV to Sales | — |
| Price to Book | 2.93 |
| Price to Cash Flow | — |
| Price to Free Cash Flow | — |
| Price to Sales | — |
| Return on Assets | -0.57% |
| Return on Equity | -0.66% |
AN2 Therapeutics Stock Splits
There have been no stock splits for AN2 Therapeutics (ANTX).
AN2 Therapeutics Dividends
There have been no dividends for AN2 Therapeutics (ANTX).